Current role of neoadjuvant and adjuvant systemic therapy for high-risk localized prostate cancer.
Dorff TB, Glode LM. Current role of neoadjuvant and adjuvant systemic therapy for high-risk localized prostate cancer. Curr Opin Urol. 2013 Jul; 23(4):366-71.